Mid-Regional Proadrenomedullin Levels in Primary Immunodeficiencies Complicated with Pulmonary Manifestations
dc.authorid | Karaca, Neslihan/0000-0002-2202-7082 | |
dc.authorid | Azarsiz, Elif/0000-0002-2887-7029 | |
dc.authorscopusid | 6505770201 | |
dc.authorscopusid | 15762370000 | |
dc.authorscopusid | 7006914574 | |
dc.authorwosid | Karaca, Neslihan/AAW-1924-2020 | |
dc.authorwosid | Azarsiz, Elif/J-2034-2015 | |
dc.contributor.author | Azarsiz, Elif | |
dc.contributor.author | Karaca, Neslihan | |
dc.contributor.author | Kutukculer, Necil | |
dc.date.accessioned | 2023-01-12T19:51:32Z | |
dc.date.available | 2023-01-12T19:51:32Z | |
dc.date.issued | 2022 | |
dc.department | N/A/Department | en_US |
dc.description.abstract | The development of lower respiratory complications in children with primary immunodeficiencies characterized by recurrent infections significantly contributes to morbidity and mortality. This is clinically more important and specific in the evaluation of prognosis. The inflammatory response that develops throughout the clinical process can cause the release of several biomarkers. This study aimed to evaluate the inflammatory biomarker mid-regional pro-adrenomedullin (MR-proADM) levels by distribution of lower respiratory tract complications. Plasma MR-proADM levels were measured in children with (n = 52) and without (n = 103) lower respiratory tract complications. The complicated group was also evaluated as infective and non-infective groups. The median MR-proADM levels were higher in the complicated cases (p = 0.175). It was 205.5 (73.4- 562.6) ng/L in the infective group while it was 96.1 (26.1-43.3) ng/L in the non-infective group and the difference between the two groups was statistically significant (p = 0.003). The predictive value of MR-proADM (AUC = 0.749, p = 0.003) was statistically significant compared to CRP (AUC = 0.330, p = 0.040) and SAA (AUC = 0.261, p = 0.004) in the infective group. This study evidences that the MR-proADM levels are higher in PID cases with infective pulmonary complications. Among other markers, MR-proADM appears to be a particularly good predictive inflammation marker for these children. | en_US |
dc.description.sponsorship | Ege University Scientific Research Projects Coordination Unit [TKB-2019-20570] | en_US |
dc.description.sponsorship | We thank to Ege University Scientific Research Projects Coordination Unit (Career Start Support Project Number: TKB-2019-20570). | en_US |
dc.identifier.doi | 10.1007/s12291-022-01061-9 | |
dc.identifier.issn | 0970-1915 | |
dc.identifier.issn | 0974-0422 | |
dc.identifier.issn | 0970-1915 | en_US |
dc.identifier.issn | 0974-0422 | en_US |
dc.identifier.scopus | 2-s2.0-85137759167 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s12291-022-01061-9 | |
dc.identifier.uri | https://hdl.handle.net/11454/76289 | |
dc.identifier.wos | WOS:000852135400001 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer India | en_US |
dc.relation.ispartof | Indian Journal Of Clinical Biochemistry | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Adrenomedullin | en_US |
dc.subject | Biomarkers | en_US |
dc.subject | Children | en_US |
dc.subject | Inflammation | en_US |
dc.subject | Respiratory tract infections | en_US |
dc.subject | Community-Acquired Pneumonia | en_US |
dc.subject | Pro-Adrenomedullin | en_US |
dc.subject | Prognostic Marker | en_US |
dc.subject | Prediction | en_US |
dc.subject | Diseases | en_US |
dc.subject | Infections | en_US |
dc.subject | Biomarkers | en_US |
dc.subject | Management | en_US |
dc.title | Mid-Regional Proadrenomedullin Levels in Primary Immunodeficiencies Complicated with Pulmonary Manifestations | en_US |
dc.type | Article | en_US |